دراسة إحصائية لانتشار متلازمة الألم العضلي الليفي وتشخيصها في المجتمع السوري

مروان  خطاب; محمد كف الغزال; شادن  حزوري; لين  شقفة; نجاح قمر الدين

doi:10.5281/zenodo.19851706

Authors

Dr. Marwan Khattab Al Wataniya Private University
Muhamad Kaf Alghazal Al Wataniya Private University
Shaden Hazzouri Al Wataniya Private University
Leen Shekfah Al Wataniya Private University
Najah Kamar aldin Al Wataniya Private University

DOI:

https://doi.org/10.5281/zenodo.19851706

Keywords:

Fibromyalgia, Prevalence, Demographic Factors, Social Factors

Abstract

Fibromyalgia syndrome is a musculoskeletal disorder that causes chronic pain, muscle spasms, and discomfort in the connective tissues. The pain is often widespread and is accompanied by severe fatigue, sleep disturbances, memory issues, and mood fluctuations. This study aimed to assess the prevalence and diagnosis of fibromyalgia in the Syrian community through a statistical analysis involving 452 participants of various ages and genders, using diagnostic tools approved by the American College of Rheumatology. The results showed a fibromyalgia prevalence rate of 17.5%, with a higher rate among women (19.0%) compared to men (14.2%), though this difference was not statistically significant. Symptom severity increased with age, with those over 50 years old reporting the highest pain levels. There was a strong correlation between the Widespread Pain Index (WPI) and Symptom Severity Score (SSS), indicating that higher pain levels were associated with more severe accompanying symptoms. Additionally, non-working individuals were more likely to be affected than those employed, suggesting a role for social factors and physical activity in disease risk. These findings highlight the need to raise public and medical awareness about fibromyalgia and to develop comprehensive diagnostic and therapeutic strategies that address psychological and social aspects alongside medical management, with an emphasis on physical activity and psychological support to improve patients’ quality of life.

Downloads

Download data is not yet available.

References

[1] M. Di Carlo, B. Bianchi, F. Salaffi, G. Pellegrino, C. Iannuccelli, V. Giorgi, and P. Sarzi-Puttini, “Fibromyalgia: One year in review 2024,” Clinical and Experimental Rheumatology, vol. 42, no. 6, pp. 1141–1149, Jun. 2024, doi: 10.55563/clinexprheumatol/mbyi1n.

[2] M. Gyorfi, A. Rupp, and A. Abd-Elsayed, “Fibromyalgia pathophysiology,” Biomedicines, vol. 10, no. 12, Art. no. 3070, Dec. 2022, doi: 10.3390/biomedicines10123070.

[3] D. J. Clauw, K. Phillips, D. A. Williams, S. A. McLean, and R. E. Harris, “Central pain mechanisms in fibromyalgia: A systematic review of neurotransmitter dysregulation and central sensitization,” Pain, vol. 164, no. 5, pp. 895–911, May 2023.

[4] S. Bourgaize et al., “Autonomic dysfunction in fibromyalgia: A systematic review,” Pain Medicine, vol. 24, no. 2, pp. 203–215, Feb. 2023.

[5] F. Wolfe et al., “Fibromyalgia diagnosis: Biomarkers and clinical criteria,” Nature Reviews Rheumatology, vol. 19, no. 6, pp. 347–361, Jun. 2023.

[6] A. P. Marques et al., “Global prevalence of fibromyalgia: A systematic review and meta-analysis,” Pain Reports, vol. 8, no. 2, Art. no. e1064, Mar. 2023.

[7] W. Häuser et al., “Prevalence and diagnosis of fibromyalgia in North America and Europe,” Journal of Pain Research, vol. 15, pp. 123–135, Jan. 2022.

[8] P. Sarzi-Puttini et al., “Fibromyalgia epidemiology and awareness in Africa and Asia: Challenges and perspectives,” International Journal of Rheumatic Diseases, vol. 24, no. 4, pp. 456–467, Apr. 2021.

[9] A. Marques et al., “Improved diagnostic approaches and fibromyalgia prevalence in South America,” Rheumatology International, vol. 41, no. 7, pp. 1153–1162, Jul. 2021.

[10] J. N. Ablin and H. Amital, “Epidemiology and diagnostic challenges of fibromyalgia in the Middle East,” Middle East Journal of Rheumatology, vol. 32, no. 1, pp. 22–30, Jan. 2023.

[11] A. Vincent et al., “Social and cultural biases in fibromyalgia diagnosis: A global perspective,” Pain Medicine, vol. 24, no. 8, pp. 1123–1135, Aug. 2023.

[12] W. Häuser, P. Sarzi-Puttini, and M. A. Fitzcharles, “Fibromyalgia syndrome: Under-, over- and misdiagnosis,” Clinical and Experimental Rheumatology, vol. 37, suppl. 116, pp. 90–97, Jan. 2019.

[13] A. Andrade et al., “Resistance exercise for fibromyalgia: A systematic review and meta-analysis of randomized controlled trials,” Sports Medicine, vol. 53, no. 4, pp. 743–761, Apr. 2023.